EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression

Aleksandra Górecka iD, Agnieszka Jura-Półtorak, Ewa M Koźma iD, Anna Szeremeta iD, Krystyna Olczyk iD, Katarzyna Komosińska-Vassev iD

Molecules · 26.09.2024 · 29 (19) · 4577

DOI: 10.3390/molecules29194577 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 26.09.2024. Verfasst von Aleksandra Górecka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowi…. Hauptthemen laut MEDLINE: Occludin, Haptoglobins, Biomarkers, Cholera Toxin. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Considering the increasing worldwide prevalence of inflammatory bowel disease (IBD), the early diagnosis of this disease is extremely important. However, non-invasive diagnostic methods remain limited, while invasive techniques are the most commonly used in daily practice. Therefore, there is a serious need to find new non-invasive biomarkers of IBD.

Methods

The serum profiles of occludin, claudin-2, and zonulin were assessed in IBD patients using the ELISA method. The levels of the analyzed biomarkers were measured before and after a year of anti-inflammatory treatment, which was a tumor necrosis factor α (TNF-α) inhibitor (adalimumab) in patients with ulcerative colitis (UC) and conventional therapy in patients with Crohn’s disease (CD).

Results

In IBD patients, the serum level of occludin (p < 0.001) decreased compared to healthy individuals, while the level of claudin-2 (p < 0.001) increased. Additionally, zonulin (p < 0.01) concentration increased in CD patients compared to the control group. The highest diagnostic ability was presented by occludin measurements with the area under the curve (AUC) of 0.959 (95% CI 0.907–1) in UC and 0.948 (95% CI 0.879–1) in CD. Claudin-2 also demonstrated very good ability in diagnosing UC and CD with AUC values of 0.864 (95% CI 0.776–0.952) and 0.896 (95% CI 0.792–0.999), respectively. The ability of zonulin to diagnose CD was estimated as good with an AUC of 0.74 (95% CI 0.598–0.881). Moreover, a significant correlation was identified between C-reactive protein (CRP), claudin-2 (r = −0.37; p < 0.05), and zonulin (r = −0.44; p < 0.05) in UC patients. Treatment with adalimumab improved the level of occludin, claudin-2, and zonulin in UC patients, while anti-inflammatory conventional therapy decreased the concentration of zonulin in CD.

Conclusions

Occludin and claudin-2 measurements present significant utility in diagnosing both UC and CD, while zonulin assessments may be useful in CD diagnosis. Additionally, claudin-2 and zonulin measurements may be helpful in evaluating the intensity of the inflammatory process. Anti-TNF-α treatment improved the value of occludin, claudin-2, and zonulin, indicating its beneficial effect on the integrity of tight junctions in UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OccludinHaptoglobinsBiomarkersCholera ToxinProtein PrecursorsTight JunctionsClaudin-2HumansMaleFemaleAdultMiddle AgedInflammatory Bowel DiseasesDisease ProgressionCrohn DiseaseIntestinal MucosaClaudins

Stichwörter der Autor:innen

Crohn’s diseaseclaudin-2inflammatory bowel diseaseintestinal permeabilityoccludintight junctionsulcerative colitiszonulin

Substanzen

zonulinOccludinHaptoglobinsBiomarkersCholera ToxinProtein PrecursorsClaudin-2CLDN2 protein, humanOCLN protein, humanClaudins

Autor:innen und Institutionen

  • Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 41-200 Sosnowiec, Poland.

ORCID-Profile: Aleksandra Górecka, Ewa M Koźma, Anna Szeremeta, Krystyna Olczyk, Katarzyna Komosińska-Vassev

Förderung

  • Medical University of Silesia

Zitieren

APA

Górecka, A., Jura-Półtorak, A., Koźma, E. M., Szeremeta, A., Olczyk, K., & Komosińska-Vassev, K. (2024). Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Molecules, 29(19), 4577. https://doi.org/10.3390/molecules29194577

Vancouver

Górecka A, Jura-Półtorak A, Koźma EM, Szeremeta A, Olczyk K, Komosińska-Vassev K. Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression. Molecules. 2024;29(19):4577. doi:10.3390/molecules29194577

BibTeX
@article{Grecka2024,
  author = {Górecka, Aleksandra and Jura-Półtorak, Agnieszka and Koźma, Ewa M and Szeremeta, Anna and Olczyk, Krystyna and Komosińska-Vassev, Katarzyna},
  title = {Biochemical Modulators of Tight Junctions (TJs): Occludin, Claudin-2 and Zonulin as Biomarkers of Intestinal Barrier Leakage in the Diagnosis and Assessment of Inflammatory Bowel Disease Progression},
  journal = {Molecules},
  year = {2024},
  volume = {29},
  number = {19},
  pages = {4577},
  doi = {10.3390/molecules29194577}
}
Kostenlos starten →